CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

Hansson, O; Seibyl, J; Stomrud, E; Zetterberg, H; Trojanowski, JQ; Bittner, T; Lifke, V; ... Alzheimer's Disease Neuroimaging Initiative, .; + view all Hansson, O; Seibyl, J; Stomrud, E; Zetterberg, H; Trojanowski, JQ; Bittner, T; Lifke, V; Corradini, V; Eichenlaub, U; Batrla, R; Buck, K; Zink, K; Rabe, C; Blennow, K; Shaw, LM; Swedish BioFINDER study group, .; Alzheimer's Disease Neuroimaging Initiative, .; - view fewer (2018) CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimer's & Dementia 10.1016/j.jalz.2018.01.010 . (In press). Green open access

https://ift.tt/2NJj1Vu